Scailyte is a precision medicine company that develops next-generation diagnostic and companion diagnostic solutions using its proprietary ScaiVision explainable AI platform. By integrating high-resolution multimodal omics and single-cell data with clinical outcomes, Scailyte discovers predictive biomarkers, deciphers complex disease biology, and translates these insights into clinically validated assays and decision support tools. The company focuses on challenging therapeutic areas such as oncology, immunology, and immune-mediated diseases, helping biopharma partners and clinicians match patients to the most effective therapies and overcome the efficacy gap in modern medicine.